Pitt BioForge Announces Successful Completion of Advanced Manufacturing of Microarray Patches with Panther Life Sciences ...
Max Weis is now president and chief operating officer of VitalPath, which specializes in complex catheters and precision ...
The Trump administration's cuts to NIH funding affected approiximately 1 in 30 clinical trials and more than 74 ,000 patients.
Peytant Solutions CEO John Schorgl explains how his device startup turned a complex FDA de novo application into a lasting ...